This topic contains a solution. Click here to go to the answer

Author Question: Why have most CDS systems not shown to significantly impact patient outcomes in clinical trials, ... (Read 45 times)

jake

  • Hero Member
  • *****
  • Posts: 538
Why have most CDS systems not shown to significantly impact patient outcomes in clinical trials, despite the fact that a majority of systems have been shown to significantly improve care processes?
 
  a. CDS systems have not been evaluated in clinical trials.
  b. Very few studies have assessed the impact of CDS systems on patient outcomes.
  c. Many CDS system evaluation trials are underpowered to detect changes in care outcomes.
  d. CDS systems have been implemented and evaluated in too many diverse institutions.

Question 2

Which group would have a financial incentive to implement CDS?
 
  a. A community hospital
  b. An inner-city clinic
  c. A national insurer
  d. Depends on CDS and healthcare payment model



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nyrave

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

ANS: C
The sample sizes of many CDS system evaluation studies were too small or conducted with too short of a time period to detect changes in care outcomes.

Answer to Question 2

ANS: D
Whether a particular stakeholder group has a financial incentive to implement CDS depends on the specific CDS under consideration and the governing healthcare payment model in place.




jake

  • Member
  • Posts: 538
Reply 2 on: Jul 8, 2018
Great answer, keep it coming :)


cdmart10

  • Member
  • Posts: 332
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Walt Disney helped combat malaria by making an animated film in 1943 called The Winged Scourge. This short film starred the seven dwarfs and taught children that mosquitos transmit malaria, which is a very bad disease. It advocated the killing of mosquitos to stop the disease.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

The familiar sounds of your heart are made by the heart's valves as they open and close.

For a complete list of videos, visit our video library